Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes

Experimental Biology and Medicine

Volumn 233, Issue 9, 2008, Pages 1109-1123

  Hayden, Melvin R ^a,d   Karuparthi, Poorna R ^a   Habibi, Javad ^a,b   Lastra, Guido ^a,b   Patel, Kamlesh ^a   Wasekar, Chetan ^a   Manrique, Camila Margarita ^a,b   Ozerdem, Ugur ^c   Stas, Sameer ^a   Sowers, James R ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Amylin; Angiogenesis; Apoptosis; Beta cell; Exocrine pancreas; Islet amyloid; Islet fibrosis

Indexed keywords

AMYLIN; AMYLOID; ACTIN; ANTIBODY; PEPTIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ADIPOGENESIS; AMYLOIDOSIS; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAPILLARY; COLLAGEN DISEASE; CONTROLLED STUDY; EXOCRINE SECRETION; MALE; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PERICYTE; RAT; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; AGING; ANIMAL; DISEASE MODEL; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; METABOLISM; PANCREAS; PANCREAS DISEASE; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE;

RATTUS;

ACTINS; AGING; AMYLOID; ANIMALS; ANTIBODIES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SMOOTH; PANCREAS, EXOCRINE; PANCREATIC DISEASES; PEPTIDES; PERICYTES; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 52649164050     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0709-RM-251     Document Type: Article

References (40)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetes Med. 14:S1-S85, 1997.
2. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 29:6S9-6S18, 2003.
3. Hayden MR, Stump C, Sowers JR. Organ involvement in cardiometabolic syndrome. J Cardiometab Syndr 1(1):16-24, 2006.
4. Hayden MR, Sowers JR. Redox imbalance in diabetes. Antioxid Redox Signal 9(7):865-867, 2007.
5. Arslanian SA. Type 2 diabetes mellitus in children: pathophysiology and risk factors. J Pediatr Endocrinol Metab 13(suppl 6):1385-1394, 2000.
6. Hayden MR, Sowers JR. Isletopathy in type 2 diabetes mellitus: implications of islet RAS, islet fibrosis, islet amyloid, remodeling and oxidative stress. Antioxid Redox Signal 9(7):891-910, 2007.
7. Hayden MR, Karuparthi PR, Habibi J, Wasekar C, Lastra G, Manrique C, Stas S, Sowers JR. Ultrastructural islet study of early fibrosis in the Ren2 rat model of hypertension. Emerging role of the islet pancreatic pericyte-stellate cell. JOP 8(6):725-738, 2007.
8. Cefalu WT. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J 47(3): 186-198, 2006.
9. Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ. Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 42(4):427-434, 1999.
10. Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cnop M, Prigeon RL, Kahn SE. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52(2):372-379, 2003.
11. Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53(6):1509-1516, 2004.
12. Matveyenko AV, Butler PC. β-Cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes. Diabetes 55(7):2106-2114, 2006.
13. Matveyenko AV, Butler PC. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J 47(3):225-233, 2006.
14. Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cnop M, Prigeon RL, Kahn SE. Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52(2):372-379, 2003.
15. Henson MS, O'Brien TD. Feline models of type 2 diabetes mellitus. ILAR J 47(3):234-242, 2006.
16. Howard CF Jr. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29(5):301-306, 1986.
17. Hayden MR, Karuparthi PR, Manrique CM, Lastra G, Habibi J, Sowers JR. Longitudinal ultrastructure study of islet amyloid in the HIP rat model of type 2 diabetes mellitus. Exp Biol Med (Maywood) 232(6):772-779, 2007.
18. Hayden MR, Chowdhury NA, Cooper SA, Whaley-Connell A, Habibi J, Witte L, Wiedmeyer C, Manrique CM, Lastra G, Ferrario C, Stump C, Sowers JR. Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat. Am J Physiol Renal Physiol 292(2):F861-F867, 2007.
19. Rajkumar VS, Howell K, Csiszar K, Denton CP, Black CM, Abraham DJ. Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther 7(5):R1113-R1123, 2005.
20. Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G, Ravazzola M, Orci L. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 37:315-321, 1989.
21. Habibi J, Whaley-Connell A, Qazi MA, Hayden MR, Cooper SA, Tramontano A, et al. Rosuvastatin, a HMG-CoA reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats. Endocrinology 148(5):2181-2188, 2007.
22. Tikellis C, Wookey PJ, Candido R, Andrikopoulos S, Thomas MC, Cooper ME. Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat. Diabetes 53(4):989-997, 2004.
23. Hayden MR. Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus. J Cardiometab Syndr 2(1):70-75, 2007.
24. Hughes SJ, Clark A, McShane P, Contractor HH, Gray DW, Johnson PR. Characterization of collagen VI within the islet-exocrine interface of the human pancreas: implications for clinical islet isolation? Transplantation 81(3):423-426, 2006.
25. Bertelli E, Bendayan M. Association between endocrine pancreas and ductal system. More than an epiphenomenon of endocrine differentiation and development? J Histochem Cytochem 53(9):1071-1086, 2005.
26. Leung PS, Carlsson PO. Pancreatic islet renin angiotensin system: its novel roles in islet function and in diabetes mellitus. Pancreas 30(4):293-298, 2005.
27. Ozerdem U, Stallcup WB. Early contribution of pericytes to angiogenic sprouting and tube formation. Angiogenesis 6(3):241-249, 2003.
28. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 97(6):512-523, 2005.
29. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104(7):2084-2086, 2004.
30. Ozerdem U, Alitalo K, Salven P, Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Invest Ophthalmol Vis Sci 46(10):3502-3506, 2005.
31. Shojaee N, Patton WF, Hechtman HB, Shepro D. Myosin translocation in retinal pericytes during free-radical induced apoptosis. J Cell Biochem 75(1):118-129, 1999.
32. Yamagishi S, Takeuchi M, Matsui T, Nakamura K, Imaizumi T, Inoue H. Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression. FEBS Lett 579(20):4265-4270, 2005.
33. Brignardello E, Beltramo E, Molinatti PA, Aragno M, Gatto V, Tamagno E, Danni O, Porta M, Boccuzzi G. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. J Endocrinol 158(1):21-26, 1998.
34. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 14(1):15-23, 2003.
35. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. Chondrogenic and adipogenic potential of micro- vascular pericytes. Circulation 110(15):2226-2232, 2004.
36. Davidoff MS, Middendorff R, Enikolopov G, Riethmacher D, Holstein AF, Muller D. Progenitor cells of the testosterone-producing Leydig cells revealed. J Cell Biol 167(5):935-944, 2004.
37. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9(3):255-267, 2007.
38. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11):2204-2213, 2006.
39. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 51(10):3107-3112, 2002.
40. Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes 52(11):2759-2766, 2003.